| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Departments of Internal Medicine (V.A.D., P.M.v.H., P.M.v.K., A.-J.v.d.L., S.W.L., L.J.H.) and Immunology (P.M.v.H., A.W.L.), Erasmus Medical Center, 3015 GD, Rotterdam, The Netherlands
Address all correspondence and requests for reprints to: L. J. Hofland, Ph.D., Department of Internal Medicine, Room BD277, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. E-mail: hofland{at}inw3.fgg.eur.nl.
Cells of the human immune system have been shown to express somatostatin receptors (sst). The expression of sst suggests a functional role of the peptide somatostatin (SS). However, SS expression has not been demonstrated yet in different human immune tissues. Therefore, we investigated by RT-PCR the expression of both SS and cortistatin (CST), a SS-like peptide, in various human lymphoid tissues and immune cells. We detected SS mRNA expression in the human thymus only, while not in thymocytes. CST mRNA was clearly expressed in the immune cells, lymphoid tissues, and bone marrow. Using quantitative RT-PCR, significant differences in expression levels between tissues were demonstrated. Expression of CST mRNA was up-regulated during differentiation of monocytes into macrophages and dendritic cells and could be up-regulated by lipopolysaccharide stimulation. Two differently sized cDNA fragments of CST were detected in the majority of cells and tissues. However, although both fragments were detected in nearly all T-cell lines (7 of 8), most of the B-cell lines expressed the short fragment only (8 of 10). Using autoradiography, we showed that CST displaced [125I-Tyr3]octreotide binding with relatively high affinity on human thymic tissue and sst2-expressing cells. This is the first extensive study demonstrating that human lymphoid tissues and immune cells express different levels of CST mRNA and that its expression can be regulated. On the basis of these observations, we hypothesize a role for CST as an endogenous ligand of at least the sst2 receptor in the human immune system, rather than SS itself.
This work was supported by a grant from the Dutch Organization for Scientific Research (NWO).
Abbreviations: CST, Cortistatin; HPRT, hypoxanthine-guanine phosphoribosyl transferase; LPS, lipopolysaccharide; PBMC, peripheral blood mononuclear cells; Q-PCR, quantitative RT-PCR; SS, somatostatin; sst, somatostatin receptor(s); TEC, thymic epithelial cells.
This article has been cited by other articles:
![]() |
N. Kimura, N. Takamatsu, Y. Yaoita, R Y. Osamura, and N. Kimura Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation J. Mol. Endocrinol., February 1, 2008; 40(2): 75 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gonzalez-Rey, A. Chorny, R. G Del Moral, N. Varela, and M. Delgado Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses Ann Rheum Dis, May 1, 2007; 66(5): 582 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Armani, E. Catalani, A. Balbarini, P. Bagnoli, and D. Cervia Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages J. Leukoc. Biol., March 1, 2007; 81(3): 845 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rubinfeld, M. Hadani, G. Barkai, J. E. Taylor, M. D. Culler, and I. Shimon Cortistatin Inhibits Growth Hormone Release from Human Fetal and Adenoma Pituitary Cells and Prolactin Secretion from Cultured Prolactinomas J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2257 - 2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gonzalez-Rey, A. Chorny, N. Varela, G. Robledo, and M. Delgado Urocortin and Adrenomedullin Prevent Lethal Endotoxemia by Down-Regulating the Inflammatory Response Am. J. Pathol., June 1, 2006; 168(6): 1921 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gonzalez-Rey, A. Chorny, G. Robledo, and M. Delgado Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia J. Exp. Med., March 20, 2006; 203(3): 563 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gonzalez-Rey, N. Varela, A. F. Sheibanie, A. Chorny, D. Ganea, and M. Delgado Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. PNAS, March 14, 2006; 103(11): 4228 - 4233. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seboek, P. Linscheid, H. Zulewski, I. Langer, M. Christ-Crain, U. Keller, and B. Muller Somatostatin Is Expressed and Secreted by Human Adipose Tissue upon Infection and Inflammation J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4833 - 4839. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A.S.H. Dalm, L. J. Hofland, C. M. Mooy, M. A. Waaijers, P. M. van Koetsveld, A. W. Langerak, F. T.J. Staal, A.-J. van der Lely, S. W.J. Lamberts, and M. P. van Hagen Somatostatin Receptors in Malignant Lymphomas: Targets for Radiotherapy? J. Nucl. Med., January 1, 2004; 45(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. S. H. Dalm, P. M. van Hagen, P. M. van Koetsveld, S. Achilefu, A. B. Houtsmuller, D. H. J. Pols, A.-J. van der Lely, S. W. J. Lamberts, and L. J. Hofland Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E344 - E353. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |